Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules

Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules

US Patent 7482327 · Granted Jan 27, 2009

Estimated economic value: $62,964,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating or reducing the risk of cardiovascular events and related di2024
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2020
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
SGLT-2 inhibitors for treating metabolic disorders in patients with renal impair2019
Methods for treating dermatomyositis or polymyositis by administering a soluble 2018
Methods for treating scleroderma by administering a soluble CTLA4 molecule2016
Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule2014
Methods for treating juvenile rheumatoid arthritis by administering a soluble CT2014
Methods for treating type I diabetes mellitus by administering a soluble CTLA4 m2013
Method for treating an autoimmune disease using a soluble CTLA4 molecule and a D2012
Method for treating a rheumatic disease using a soluble TLA4 molecule2012
Methods for treating cardiovascular disease using a soluble CTLA4 molecule2010